Using mice to model Alzheimer's dementia: an overview of the clinical disease and the preclinical behavioral changes in 10 mouse models

SJ Webster, AD Bachstetter, PT Nelson… - Frontiers in …, 2014 - frontiersin.org
The goal of this review is to discuss how behavioral tests in mice relate to the pathological
and neuropsychological features seen in human Alzheimer's disease (AD), and present a …

Neuropathology and biochemistry of Aβ and its aggregates in Alzheimer's disease

DR Thal, J Walter, TC Saido, M Fändrich - Acta neuropathologica, 2015 - Springer
Alzheimer's disease (AD) is characterized by β-amyloid plaques and intraneuronal τ
aggregation usually associated with cerebral amyloid angiopathy (CAA). Both β-amyloid …

The flavonoid quercetin ameliorates Alzheimer's disease pathology and protects cognitive and emotional function in aged triple transgenic Alzheimer's disease model …

AM Sabogal-Guáqueta, JI Muñoz-Manco… - …, 2015 - Elsevier
Alzheimer's disease (AD) is the most common senile dementia in the world. Although
important progress has been made in understanding the pathogenesis of AD, current …

Protein restriction slows the development and progression of pathology in a mouse model of Alzheimer's disease

R Babygirija, MM Sonsalla, J Mill, I James… - Nature …, 2024 - nature.com
Dietary protein is a critical regulator of metabolic health and aging. Low protein diets are
associated with healthy aging in humans, and dietary protein restriction extends the lifespan …

IL-17 triggers the onset of cognitive and synaptic deficits in early stages of Alzheimer's disease

HC Brigas, M Ribeiro, JE Coelho, R Gomes… - Cell reports, 2021 - cell.com
Neuroinflammation in patients with Alzheimer's disease (AD) and related mouse models has
been recognized for decades, but the contribution of the recently described meningeal …

Amyloid-β and tau synergistically impair the oxidative phosphorylation system in triple transgenic Alzheimer's disease mice

V Rhein, X Song, A Wiesner, LM Ittner… - Proceedings of the …, 2009 - pnas.org
Alzheimer's disease (AD) is characterized by amyloid-beta (Aβ)-containing plaques,
neurofibrillary tangles, and neuron and synapse loss. Tangle formation has been …

A non-transgenic mouse model (icv-STZ mouse) of Alzheimer's disease: similarities to and differences from the transgenic model (3xTg-AD mouse)

Y Chen, Z Liang, J Blanchard, CL Dai, S Sun… - Molecular …, 2013 - Springer
Alzheimer's disease (AD) can be divided into sporadic AD (SAD) and familial AD (FAD).
Most AD cases are sporadic and result from multiple etiologic factors, including …

[HTML][HTML] The endoplasmic reticulum stress and unfolded protein response in Alzheimer's disease: a calcium dyshomeostasis perspective

D Lim, L Tapella, G Dematteis, AA Genazzani… - Ageing research …, 2023 - Elsevier
Protein misfolding is prominent in early cellular pathology of Alzheimer's disease (AD),
implicating pathophysiological significance of endoplasmic reticulum stress/unfolded protein …

Rodent models for Alzheimer's disease drug discovery

D Puzzo, W Gulisano, A Palmeri… - Expert opinion on drug …, 2015 - Taylor & Francis
Introduction: Alzheimer's disease (AD) is a neurodegenerative disorder characterized by
memory loss and personality changes, leading to dementia. Histopathological hallmarks are …

Exosomes in pathogenesis, diagnosis, and treatment of Alzheimer's disease

L Jiang, H Dong, H Cao, X Ji… - … medical journal of …, 2019 - pmc.ncbi.nlm.nih.gov
Alzheimer's disease (AD) is a neurodegenerative disorder characterized by the
accumulation of β-amyloid peptide 1-42 and phosphorylation of tau protein in the brain …